医学
哭
安慰剂
益生菌
婴儿绞痛
母乳喂养
钙蛋白酶
内科学
动物双歧杆菌
胃肠病学
随机对照试验
生活质量(医疗保健)
儿科
粪便
安慰剂组
婴儿配方奶粉
乳果糖
随机化
便秘
意向治疗分析
功能性便秘
临床终点
低过敏性
粪钙保护素
母乳
双歧杆菌
牛奶过敏
乳铁蛋白
临床试验
膨胀
作者
K. Chen,G. Zhang,H. Xie,L. You,H. Li,Y. Zhang,C. Du,S. Xu,C. Melsaether,S. Yuan
出处
期刊:Beneficial Microbes
[Wageningen Academic Publishers]
日期:2021-09-22
卷期号:12 (6): 531-540
被引量:32
摘要
To evaluate the administration of Bifidobacterium animalis subsp. lactis, BB-12® (BB-12) on infant colic in breastfed infants, a double-blind, placebo-controlled randomised study was conducted in Chengdu, China from April 2016 to October 2017 with 192 full-term infants less than 3 months of age and meeting the ROME III criteria for infant colic. After a 1-week run-in the infants were randomly assigned to receive daily BB-12 (1×109 cfu/day) or placebo for 3 weeks. Crying/fussing time were recorded using a 24 h structured diary. The primary endpoint was the proportion of infants achieving a reduction in crying and fussing time of ≥50% from baseline. Parent's/caregiver's health related quality of life was measured using a modified PedsQL™ 2.0 Family Impact Module and immunological biomarkers were evaluated from faecal samples at baseline and after the 21-day intervention. The percentage of infants achieving a reduction in the daily crying/fussing time ≥50% after the 21-day intervention was significantly higher in the infants supplemented with BB-12 (P<0.001). The mean number of crying episodes was significantly reduced in the BB-12 group compared to the placebo group (10.0±3.0 to 5.0±1.87 vs 10.5±2.6 to 7.5±2.8, respectively) (P<0.001) and the mean daily sleep duration was markedly increased from baseline to end of intervention in the BB-12 group compared to the infants in the placebo group (60.7±104.0 vs 31.9±102.7 min/day, respectively) (P<0.001). The faecal levels of human beta defensin 2, cathelicidin, slgA, calprotectin and butyrate were statistically higher in the BB-12 group compared to the placebo group after the 21-day intervention. At the end of the intervention the parent's/caregiver's physical, emotional and social functioning scores were significantly higher for the BB-12 group compared to the placebo group (all P<0.05). Supplementation of BB-12 is effective in reducing crying and fussing in infants diagnosed with infant colic.
科研通智能强力驱动
Strongly Powered by AbleSci AI